Ohcanbohtosat - Isabelle Borget

Aiddostahte ozu
  1. 1
    Suitability of the Current Health Technology Assessment of Innovative Artificial Intelligence-Based Medical Devices: Scoping Literature Review

    Suitability of the Current Health Technology Assessment of Innovative Artificial Intelligence-Based Medical Devices: Scoping Literature Review Dahkki Line Farah, Isabelle Borget, Nicolas Martelli, Alexandre Vallée

    Almmustuhtton 2024
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Are current clinical studies on artificial intelligence-based medical devices comprehensive enough to support a full health technology assessment? A systematic review

    Are current clinical studies on artificial intelligence-based medical devices comprehensive enough to support a full health technology assessment? A systematic review Dahkki Line Farah, Julie Davaze-Schneider, Tess Martin, Pierre Nguyen, Isabelle Borget, Nicolas Martelli

    Almmustuhtton 2023
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Assessment of the Cost of Fine-Needle Aspiration Cytology as a Diagnostic Tool in Patients With Thyroid Nodules

    Assessment of the Cost of Fine-Needle Aspiration Cytology as a Diagnostic Tool in Patients With Thyroid Nodules Dahkki Isabelle Borget, Philippe Vielh, Sophie Leboulleux, Mark Allyn, Sylviane Iacobelli, Martin Schlumberger, Gérard de Pouvourville

    Almmustuhtton 2008
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    <sup>131</sup>I Effective Half-Life and Dosimetry in Thyroid Cancer Patients

    <sup>131</sup>I Effective Half-Life and Dosimetry in Thyroid Cancer Patients Dahkki Hervé Remy, Isabelle Borget, Sophie Leboulleux, Nadine Guilabert, F. Lavielle, Jérome Garsi, Claire Bournaud, Séverine Gupta, Martin Schlumberger, Marcel Ricard

    Almmustuhtton 2008
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    Body Composition Variation and Impact of Low Skeletal Muscle Mass in Patients With Advanced Medullary Thyroid Carcinoma Treated With Vandetanib: Results From a Placebo-Controlled Study

    Body Composition Variation and Impact of Low Skeletal Muscle Mass in Patients With Advanced Medullary Thyroid Carcinoma Treated With Vandetanib: Results From a Placebo-Controlled S... Dahkki Marie-Hélène Massicotte, Isabelle Borget, Sophie Broutin, Vickie E. Baracos, Sophie Leboulleux, Éric Baudin, Angélo Paci, Alain Deroussent, Martin Schlumberger, S. Antoun

    Almmustuhtton 2013
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  6. 6
    Endocrine Effects of the Tyrosine Kinase Inhibitor Vandetanib in Patients Treated for Thyroid Cancer

    Endocrine Effects of the Tyrosine Kinase Inhibitor Vandetanib in Patients Treated for Thyroid Cancer Dahkki Maryse Brassard, B. Néraud, Séverine Trabado, Sylvie Salenave, Sylvie Brailly‐Tabard, Isabelle Borget, Éric Baudin, Sophie Leboulleux, Philippe Chanson, Martin Schlumberger, Jacques Young

    Almmustuhtton 2011
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  7. 7
    Ultrasensitive serum thyroglobulin measurement is useful for the follow-up of patients treated with total thyroidectomy without radioactive iodine ablation

    Ultrasensitive serum thyroglobulin measurement is useful for the follow-up of patients treated with total thyroidectomy without radioactive iodine ablation Dahkki C. Nascimento, Isabelle Borget, Frédéric Troalen, Abir Al Ghuzlan, Désirèe Deandreis, Dana M. Hartl, J. Lumbroso, C. Chougnet, Éric Baudin, M. Schlumberger, Sophie Leboulleux

    Almmustuhtton 2013
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  8. 8
    High-dose mitotane strategy in adrenocortical carcinoma: prospective analysis of plasma mitotane measurement during the first 3 months of follow-up

    High-dose mitotane strategy in adrenocortical carcinoma: prospective analysis of plasma mitotane measurement during the first 3 months of follow-up Dahkki Sophie Giraud, Sophie Leboulleux, Isabelle Borget, Angélo Paci, Jacques Young, Abir Al Ghuzlan, Désirèe Deandreis, Laurence Drouard, Antoine Tabarin, Philippe Chanson, Martin Schlumberger, Éric Baudin

    Almmustuhtton 2011
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  9. 9
    Cost of cancer diagnosis using next-generation sequencing targeted gene panels in routine practice: a nationwide French study

    Cost of cancer diagnosis using next-generation sequencing targeted gene panels in routine practice: a nationwide French study Dahkki Patricia Marino, Rajae Touzani, Lionel Perrier, Étienne Rouleau, Dede Sika Kossi, Zhaomin Zou, Nathanaël Charrier, Nicolas Goardon, Claude Preudhomme, Isabelle Durand‐Zaleski, Isabelle Borget, Sandrine Baffert

    Almmustuhtton 2018
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  10. 10
    High level of chromosomal instability in circulating tumor cells of ROS1-rearranged non-small-cell lung cancer

    High level of chromosomal instability in circulating tumor cells of ROS1-rearranged non-small-cell lung cancer Dahkki Emma Pailler, Nathalie Auger, Colin R. Lindsay, Philippe Vielh, A. Islas-Morris-Hernandez, Isabelle Borget, Maud Ngo‐Camus, David Planchard, Jean‐Charles Soria, B. Besse, F Farace

    Almmustuhtton 2015
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  11. 11
    Surgery for Neck Recurrence of Differentiated Thyroid Cancer: Outcomes and Risk Factors

    Surgery for Neck Recurrence of Differentiated Thyroid Cancer: Outcomes and Risk Factors Dahkki Livia Lamartina, Isabelle Borget, H. Mirghani, Abir Al Ghuzlan, A. Berdelou, François Bidault, Désirèe Deandreis, Éric Baudin, Jean‐Paul Travagli, Martin Schlumberger, Dana M. Hartl, Sophie Leboulleux

    Almmustuhtton 2017
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  12. 12
    Persistent disease and recurrence in differentiated thyroid cancer patients with undetectable postoperative stimulated thyroglobulin level

    Persistent disease and recurrence in differentiated thyroid cancer patients with undetectable postoperative stimulated thyroglobulin level Dahkki C. Nascimento, Isabelle Borget, Abir Al Ghuzlan, Désirèe Deandreis, L. Chami, J P Travagli, Dana M. Hartl, J. Lumbroso, C. Chougnet, Ludovic Lacroix, Éric Baudin, Martin Schlumberger, Sophie Leboulleux

    Almmustuhtton 2010
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  13. 13
    Detection of Circulating Tumor Cells Harboring a Unique <i>ALK</i> Rearrangement in <i>ALK</i>-Positive Non–Small-Cell Lung Cancer

    Detection of Circulating Tumor Cells Harboring a Unique <i>ALK</i> Rearrangement in <i>ALK</i>-Positive Non–Small-Cell Lung Cancer Dahkki Emma Pailler, Julien Adam, Amélie Barthelemy, Marianne Oulhen, Nathalie Auger, Alexander Valent, Isabelle Borget, David Planchard, Mélissa Taylor, Fabrice André, Jean Charles Soria, Philippe Vielh, Benjamin Besse, Françoise Farace

    Almmustuhtton 2013
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  14. 14
    Tyrosine kinase inhibitor treatments in patients with metastatic thyroid carcinomas: a retrospective study of the TUTHYREF network

    Tyrosine kinase inhibitor treatments in patients with metastatic thyroid carcinomas: a retrospective study of the TUTHYREF network Dahkki Marie-Hélène Massicotte, Maryse Brassard, M. Claude-Desroches, Isabelle Borget, F. Bonichon, Anne‐Laure Giraudet, Christine Do Cao, C. Chougnet, Sophie Leboulleux, Éric Baudin, Martin Schlumberger, Christelle de la Fouchardière

    Almmustuhtton 2014
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  15. 15
    Antiangiogenic Tyrosine Kinase Inhibitors: Occurrence and Risk Factors of Hemoptysis in Refractory Thyroid Cancer

    Antiangiogenic Tyrosine Kinase Inhibitors: Occurrence and Risk Factors of Hemoptysis in Refractory Thyroid Cancer Dahkki Livia Lamartina, Serena Ippolito, Marion Danis, François Bidault, Isabelle Borget, A. Berdelou, Abir Al Ghuzlan, Dana M. Hartl, Pierre Blanchard, M. Terroir, Désirèe Deandreis, Martin Schlumberger, Éric Baudin, Sophie Leboulleux

    Almmustuhtton 2016
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  16. 16
    Circulating Tumor Cells with Aberrant <i>ALK</i> Copy Number Predict Progression-Free Survival during Crizotinib Treatment in <i>ALK</i>-Rearranged Non–Small Cell Lung Cancer Patients

    Circulating Tumor Cells with Aberrant <i>ALK</i> Copy Number Predict Progression-Free Survival during Crizotinib Treatment in <i>ALK</i>-Rearranged Non–Small Cell Lung Cancer Patie... Dahkki Emma Pailler, Marianne Oulhen, Isabelle Borget, Jordi Remón, Kirsty Ross, Nathalie Auger, Fanny Billiot, Maud Ngo Camus, Frédéric Commo, Colin R. Lindsay, David Planchard, Jean‐Charles Soria, Benjamin Besse, Françoise Farace

    Almmustuhtton 2017
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  17. 17
    Long-Term Follow-Up of Patients with Papillary and Follicular Thyroid Cancer: A Prospective Study on 715 Patients

    Long-Term Follow-Up of Patients with Papillary and Follicular Thyroid Cancer: A Prospective Study on 715 Patients Dahkki Maryse Brassard, Isabelle Borget, Agathe Edet‐Sanson, Anne‐Laure Giraudet, O. Mundler, Michel Toubeau, F. Bonichon, Françoise Borson‐Chazot, Laurence Leenhardt, Claire Schvartz, C. Dejax, Isabelle Brenot‐Rossi, Marie‐Elisabeth Toubert, Massimo Torlontano, E Benhamou, Martin Schlumberger

    Almmustuhtton 2011
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  18. 18
    Post-first-line FOLFOX chemotherapy for grade 3 neuroendocrine carcinoma

    Post-first-line FOLFOX chemotherapy for grade 3 neuroendocrine carcinoma Dahkki Julien Hadoux, David Malka, David Planchard, Jean–Yves Scoazec, Caroline Caramella, J. Guigay, Valérie Boige, Sophie Leboulleux, Pascal Burtin, A. Berdelou, Yohann Loriot, Pierre Duvillard, C. Chougnet, Désirèe Deandreis, Martin Schlumberger, Isabelle Borget, Michel Ducreux, Éric Baudin

    Almmustuhtton 2015
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  19. 19
    Strategies of Radioiodine Ablation in Patients with Low-Risk Thyroid Cancer

    Strategies of Radioiodine Ablation in Patients with Low-Risk Thyroid Cancer Dahkki Martin Schlumberger, Bogdan Catargi, Isabelle Borget, Désirèe Deandreis, Slimane Zerdoud, B. Bridji, Stéphane Bardet, Laurence Leenhardt, D. Bastié, Claire Schvartz, Pierre Véra, Olivier Morel, Danielle Benisvy, Claire Bournaud, Franccoise Bonichon, C. Dejax, Marie‐Elisabeth Toubert, Sophie Leboulleux, Marcel Ricard, E Benhamou

    Almmustuhtton 2012
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  20. 20
    Quality of Life and Cost-Effectiveness Assessment of Radioiodine Ablation Strategies in Patients With Thyroid Cancer: Results From the Randomized Phase III ESTIMABL Trial

    Quality of Life and Cost-Effectiveness Assessment of Radioiodine Ablation Strategies in Patients With Thyroid Cancer: Results From the Randomized Phase III ESTIMABL Trial Dahkki Isabelle Borget, Julia Bonastre, Bogdan Catargi, Désirèe Deandreis, Slimane Zerdoud, Daniéla Rusu, Stéphane Bardet, Laurence Leenhardt, D. Bastié, Claire Schvartz, Pierre Véra, Olivier Morel, D. Benisvy, Claire Bournaud, F. Bonichon, A. Kelly, Marie-Elisabeth Toubert, Sophie Leboulleux, Florence Journeau, E Benhamou, Martin Schlumberger

    Almmustuhtton 2015
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: